Table: begin end state 1 27 cytoplasmic 28 49 transmembrane 50 55 non-cytoplasmic 56 76 transmembrane 77 103 cytoplasmic 104 129 transmembrane 130 134 non-cytoplasmic 135 153 transmembrane 154 163 cytoplasmic 164 183 transmembrane 184 207 non-cytoplasmic 208 230 transmembrane 231 247 cytoplasmic 248 268 transmembrane 269 285 non-cytoplasmic 286 311 transmembrane 312 337 cytoplasmic 338 360 transmembrane 361 365 non-cytoplasmic 366 389 transmembrane 390 408 cytoplasmic 409 429 transmembrane 430 434 non-cytoplasmic 435 455 transmembrane 456 468 cytoplasmic
Input: >GFF4621 FitnessBrowser__WCS417:GFF4621 MTTPDNGFAEITHRELGLRRQLTSGQMSMIAIGGAIGTGLFMGSAYAIGYAGPSVLVSYA IGALITLLLMGCLAEMTVAHSTSGSFGAYAEFYISPLAGFLVRYAYWAAIVLAVGAEVTA VAMYMKYWFANVPEWVWIVSFSSVLILLNAISVKTFGNFEYWFSTIKISAIVGFIILAVY VVFGSGNPQYGVQNYTAHDGFFPHGLSGMWIAVIVSIFSYLSVEMIAVAAGEAADPEQAV KKAFRATIVRLVVFYLLTLALMLAIVPWNQAGQAQSPFVTVMQTIGIPGATGVMNFVILI AALSAMNSQLYITTRMMFSLSRAGFAPKSMGALSKNGIPLNALLLSSSGIALATLLNVVY PESSFTLMMAISMFGAIFTWFMIFLTHLFFRRYRKRHGGPTLSFQLRLFPYSTLLGLVLM GAVMVTTYFTEAFKMTLVFGVPFLLILSAVYYGFFRKGRAKASNKALA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server